Literature DB >> 8626728

Stoichiometry of 2',5'-oligoadenylate-induced dimerization of ribonuclease L. A sedimentation equilibrium study.

J L Cole1, S S Carroll, L C Kuo.   

Abstract

Ribonuclease L is an endoribonuclease that is activated by binding of 2',5'-linked oligoadenylates. Activation of ribonuclease L also induces dimerization. Here, we demonstrate using equilibrium sedimentation that dimerization requires the binding of one 5'-monophosphate 2',5'-(adenosine)3 molecule per ribonuclease L monomer. No dimerization was observed in the absence of activator up to a protein concentration of 18 microM, indicating that unliganded enzyme is unable to dimerize or the association is very weak. In parallel with dimerization, enzymatic activity is also maximized at a 1:1 activator: ribonuclease L stoichiometry. The same stoichiometry for dimerization is observed using a nonphosphorylated activator 2'-5'-(adenosine)3. Adenosine triphosphate or RNA oligonucleotide substrates do not induce dimerization. The observed stoichiometry supports a model for ribonuclease L dimerization in which activator binds to monomer, which subsequently dimerizes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8626728     DOI: 10.1074/jbc.271.8.3979

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Basis for regulated RNA cleavage by functional analysis of RNase L and Ire1p.

Authors:  B Dong; M Niwa; P Walter; R H Silverman
Journal:  RNA       Date:  2001-03       Impact factor: 4.942

2.  Analysis of heterogeneous interactions.

Authors:  James L Cole
Journal:  Methods Enzymol       Date:  2004       Impact factor: 1.600

Review 3.  A scientific journey through the 2-5A/RNase L system.

Authors:  Robert H Silverman
Journal:  Cytokine Growth Factor Rev       Date:  2007-07-27       Impact factor: 7.638

Review 4.  Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response.

Authors:  Robert H Silverman
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

5.  Interferon action and apoptosis are defective in mice devoid of 2',5'-oligoadenylate-dependent RNase L.

Authors:  A Zhou; J Paranjape; T L Brown; H Nie; S Naik; B Dong; A Chang; B Trapp; R Fairchild; C Colmenares; R H Silverman
Journal:  EMBO J       Date:  1997-11-03       Impact factor: 11.598

6.  The 2'-5'-oligoadenylate synthetase 3 enzyme potently synthesizes the 2'-5'-oligoadenylates required for RNase L activation.

Authors:  Mikkel Søes Ibsen; Hans Henrik Gad; Karthiga Thavachelvam; Thomas Boesen; Philippe Desprès; Rune Hartmann
Journal:  J Virol       Date:  2014-10-01       Impact factor: 5.103

Review 7.  Diverse functions of RNase L and implications in pathology.

Authors:  Catherine Bisbal; Robert H Silverman
Journal:  Biochimie       Date:  2007-02-20       Impact factor: 4.079

8.  RNase L releases a small RNA from HCV RNA that refolds into a potent PAMP.

Authors:  Krishnamurthy Malathi; Takeshi Saito; Nannette Crochet; David J Barton; Michael Gale; Robert H Silverman
Journal:  RNA       Date:  2010-09-10       Impact factor: 4.942

9.  RNase L dimerization in a mammalian two-hybrid system in response to 2',5'-oligoadenylates.

Authors:  S Naik; J M Paranjape; R H Silverman
Journal:  Nucleic Acids Res       Date:  1998-03-15       Impact factor: 16.971

10.  Structural basis for recognition of 2',5'-linked oligoadenylates by human ribonuclease L.

Authors:  Nobutada Tanaka; Masayuki Nakanishi; Yoshio Kusakabe; Yoshikuni Goto; Yukio Kitade; Kazuo T Nakamura
Journal:  EMBO J       Date:  2004-09-23       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.